Is Athira Pharma Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ATHA) stock is to Strong Buy ATHA stock.
Out of 3 analysts, 2 (66.67%) are recommending ATHA as a Strong Buy, 1 (33.33%) are recommending ATHA as a Buy, 0 (0%) are recommending ATHA as a Hold, 0 (0%) are recommending ATHA as a Sell, and 0 (0%) are recommending ATHA as a Strong Sell.
What is ATHA's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: ATHA) forecast ROE is N/A, which is considered weak.
What is ATHA's Price Target?
According to 3 Wall Street analysts that have issued a 1 year ATHA price target, the average ATHA price target is $11.33, with the highest ATHA stock price forecast at $19.00 and the lowest ATHA stock price forecast at $5.00.
On average, Wall Street analysts predict that Athira Pharma's share price could reach $11.33 by Aug 11, 2024. The average Athira Pharma stock price prediction forecasts a potential upside of 472.37% from the current ATHA share price of $1.98.
What is ATHA's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: ATHA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 12.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.